Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Panch.Organics
Quarter-by-quarter operating performance
| Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 27.96 | 29.53 | 24.63 | 23.71 | 25.61 | 31.27 | 26.05 | 27.18 | 26.24 | 28.37 | 23.56 | 25.32 | 26.73 |
| Expenses + | 22.24 | 25.58 | 19.75 | 19.28 | 20.70 | 26.54 | 21.62 | 22.05 | 21.70 | 23.60 | 19.81 | 21.82 | 22.95 |
| Operating Profit | 5.72 | 3.95 | 4.88 | 4.43 | 4.91 | 4.73 | 4.43 | 5.13 | 4.54 | 4.77 | 3.75 | 3.50 | 3.78 |
| OPM % | 20.46% | 13.38% | 19.81% | 18.68% | 19.17% | 15.13% | 17.01% | 18.87% | 17.30% | 16.81% | 15.92% | 13.82% | 14.14% |
| Other Income + | 0.01 | 1.17 | 0.10 | 1.01 | 1.22 | 0.13 | 0.74 | 0.70 | 0.96 | 0.00 | 0.66 | 0.64 | 1.06 |
| Interest | 0.18 | 0.23 | 0.07 | 0.11 | 0.05 | 0.05 | 0.06 | 0.14 | 0.08 | 0.09 | 0.06 | 0.08 | 0.09 |
| Depreciation | 0.31 | 0.64 | 0.38 | 0.41 | 0.39 | 0.56 | 0.54 | 0.56 | 0.58 | 0.51 | 0.56 | 0.58 | 0.60 |
| Profit before tax | 5.24 | 4.25 | 4.53 | 4.92 | 5.69 | 4.25 | 4.57 | 5.13 | 4.84 | 4.17 | 3.79 | 3.48 | 4.15 |
| Tax % | 25.19% | 30.12% | 25.17% | 25.20% | 25.13% | 34.59% | 24.95% | 26.12% | 24.17% | 23.98% | 25.07% | 25.00% | 11.33% |
| Net Profit + | 3.92 | 2.99 | 3.39 | 3.69 | 4.26 | 2.78 | 3.43 | 3.79 | 3.67 | 3.17 | 2.85 | 2.61 | 3.68 |
| EPS in Rs | 3.33 | 2.54 | 2.88 | 3.13 | 3.62 | 2.11 | 2.60 | 2.88 | 2.79 | 2.41 | 2.16 | 1.98 | 2.79 |
Financials of Panch.Organics
Annual income statement trend
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 39 | 36 | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 105 | 107 | 104 |
| Expenses + | 35 | 31 | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 86 | 90 | 88 |
| Operating Profit | 4 | 5 | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 19 | 18 | 16 |
| OPM % | 11% | 13% | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% | 16% | 15% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 2 |
| Interest | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 |
| Profit before tax | 3 | 3 | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 | 18 | 16 |
| Tax % | 35% | 32% | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | 27% | 24% | |
| Net Profit + | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | 14 | 12 |
| EPS in Rs | 1.76 | 1.90 | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 10.71 | 10.47 | 9.34 |
| Dividend Payout % | 14% | 13% | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% | 7% | 8% |
Financials of Panch.Organics
Capital structure and asset base
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 13 | 13 | 13 |
| Reserves | 12 | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 84 | 112 | 121 | 125 |
| Borrowings + | 5 | 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | 5 | 4 |
| Other Liabilities + | 12 | 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 21 | 28 | 24 | 29 |
| Total Liabilities | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 171 |
| Fixed Assets + | 8 | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 14 | 18 | 19 |
| CWIP | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 6 | 15 | 17 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 |
| Other Assets + | 28 | 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 137 | 131 | 135 |
| Total Assets | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 159 | 163 | 171 |
Financials of Panch.Organics
Operating, investing and financing cash movement
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 3 | 1 | 3 | 1 | 3 | 2 | 5 | 5 | -2 | 0 | 10 | 4 |
| Cash from Investing Activity + | -1 | -1 | -2 | -2 | -1 | -1 | -2 | -1 | -0 | -34 | -7 | -16 |
| Cash from Financing Activity + | -2 | 0 | -1 | 1 | -2 | -2 | -1 | -2 | -1 | 36 | 16 | -5 |
| Net Cash Flow | 0 | 0 | -1 | 0 | -0 | 0 | 1 | 3 | -2 | 1 | 18 | -18 |
| Free Cash Flow | 2 | -0 | -0 | -1 | 2 | 1 | 4 | 3 | -3 | -4 | -0 | -12 |
| CFO/OP | 88% | 46% | 69% | 45% | 79% | 63% | 73% | 85% | 5% | 28% | 82% | 48% |
Financials of Panch.Organics
Working capital efficiency and return ratios
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130 | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 | 137 | 119 |
| Inventory Days | 124 | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 | 211 | 246 |
| Days Payable | 108 | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 | 114 | 88 |
| Cash Conversion Cycle | 146 | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 | 234 | 276 |
| Working Capital Days | 104 | 136 | 138 | 137 | 150 | 155 | 170 | 167 | 192 | 173 | 178 | 204 |
| ROCE % | 15% | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 26% | 17% | 14% |
Focused growth in six core therapy areas: cardiology, pain management, women's health, CNS, transplant, and ophthalmology, which contribute 40-50% of…
Expansion plans supported by capex of INR 200-250 crores annually, with 60% towards expansion/new products and 40% towards efficiency improvements. Key concall…
The company is confident of achieving 20%+ volume growth backed by steady ramp-up in Jammu and existing facilities. Key concall takeaways from Innova Captab…
Chronic respiratory segment in India showing over 25% growth; oncology and cardiovascular segments also strong. Key concall takeaways from Glenmark…